KR20200092692A - Composition for hangover cures - Google Patents
Composition for hangover cures Download PDFInfo
- Publication number
- KR20200092692A KR20200092692A KR1020190009909A KR20190009909A KR20200092692A KR 20200092692 A KR20200092692 A KR 20200092692A KR 1020190009909 A KR1020190009909 A KR 1020190009909A KR 20190009909 A KR20190009909 A KR 20190009909A KR 20200092692 A KR20200092692 A KR 20200092692A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- hangover
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000012141 concentrate Substances 0.000 claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 241001092040 Crataegus Species 0.000 claims abstract description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- 240000001987 Pyrus communis Species 0.000 claims description 6
- 235000014443 Pyrus communis Nutrition 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 4
- 239000000940 FEMA 2235 Substances 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- 235000009582 asparagine Nutrition 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 4
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 239000006187 pill Substances 0.000 abstract description 3
- 235000013311 vegetables Nutrition 0.000 abstract description 3
- 239000013543 active substance Substances 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 235000013361 beverage Nutrition 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 244000187664 Nerium oleander Species 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 201000006353 Filariasis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940096421 milk thistle extract Drugs 0.000 description 1
- 235000020727 milk thistle extract Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 숙취해소용 조성물에 관한 것으로서, 보다 구체적으로는 헛개나무 열매 추출 농축액에 각종의 약재 및 천연 생리활성 물질을 포함하는 숙취해소용 조성물에 관한 것이다. 본 발명의 숙취해소용 조성물은 숙취해소에 효과가 좋은 헛개나무 열매의 추출 농축액을 기반으로 각종 생약 및 식물성 생리활성 성분을 함유하고 있어, 숙취해소에 탁월한 효과가 있고, 액상, 환 등으로 조제하여 간편하게 복용할 수 있으므로 건강 기능 식품 산업상 매우 유용한 발명이다.The present invention relates to a composition for releasing a hangover, and more particularly, to a composition for releasing a hangover containing various medicinal materials and natural physiologically active substances in a concentrated extract of hawthorn fruit. The composition for relieving a hangover of the present invention contains various herbal and vegetable bioactive ingredients based on the extract concentrate of the hawthorn fruit which is effective in relieving a hangover, and has an excellent effect on relieving a hangover, and is prepared by liquid, pills, etc. Since it can be easily taken, it is a very useful invention in the health food industry.
Description
본 발명은 숙취해소용 조성물에 관한 것으로서, 보다 구체적으로는 헛개나무 열매 추출 농축액에 각종의 약재 및 천연 생리활성 물질을 포함하는 숙취해소용 조성물에 관한 것이다.The present invention relates to a composition for releasing a hangover, and more particularly, to a composition for releasing a hangover containing various medicinal materials and natural physiologically active substances in a concentrated extract of hawthorn fruit.
간은 우리 몸에서 피부 다음으로 큰 장기로서 지질의 에너지 대사작용, 각종 약물이나 알코올 등과 같은 독성물질의 해독, 담즙의 배설, 조혈, 혈액응고 및 순환 혈액량의 조절 등 많은 기능을 하는 매우 중요한 장기이다.The liver is the second largest organ in the body after the skin. It is a very important organ that has many functions such as energy metabolism of lipids, detoxification of toxic substances such as various drugs and alcohol, excretion of bile, hematopoiesis, blood coagulation, and regulation of circulating blood volume. .
체내에 흡수된 혈중 에탄올은 간세포에서 알코올 탈수소효소(alcohol dehydrogenase, ADH)에 의하여 아세트알데히드(Acetaldehyde)로 전환되고, 아세트알데히드는 아세트알데하이드 탈수소효소(acetaldehyde dehydrogenase, ALDH)에 의해 아세테이트(acetate)로 전환된 후 최종적으로 이산화탄소와 물로 분해된다.Blood ethanol absorbed in the body is converted to acetaldehyde by alcohol dehydrogenase (ADH) in hepatocytes, and acetaldehyde is converted to acetate by acetaldehyde dehydrogenase (ALDH). It is finally decomposed into carbon dioxide and water.
간기능의 주요 지표로 사용되는 GOT(Glutamic oxalacetic transaminase, AST, Asparate aminotransferase, 아스파르테이트 아미노전이요소), GPT(Glutamic pyruvate transaminase, ALT, Alanine aminotransferase, 알라닌 아미노전이요소)는 주로 간세포 내에 정상적으로 존재하면서 대사에 관여하는 효소들로 간세포가 손상을 받아 사멸할 경우에 혈액으로 유리되어 혈중 수치가 증가하게 된다.GOT (Glutamic oxalacetic transaminase, AST, Asparate aminotransferase, Aspartate aminotransferase), GPT (Glutamic pyruvate transaminase, ALT, Alanine aminotransferase, alanine aminotransferase), which is used as a major indicator of liver function, is mainly present in liver cells. Enzymes involved in metabolism, when hepatocytes are damaged and die, they are released into the blood and increase blood levels.
숙취현상은 이산화탄소와 물로 분해되지 않고 체내에 축적된 에탄올(Ethanol) 및 아세트알데히드(acetaldehyde)에 의해 구토, 설사, 어지러움, 갈증, 전신권태, 피로감, 기억상실, 복부팽만감, 소화 불량, 비타민 결핍 등 발생되는 현상이다.Hangover symptoms are not decomposed into carbon dioxide and water, but vomiting, diarrhea, dizziness, thirst, systemic boredom, fatigue, amnesia, abdominal bloating, indigestion, and vitamin deficiency due to ethanol and acetaldehyde accumulated in the body This is a phenomenon that occurs.
아세트알데히드 탈수소화 효소에는 아세트알데히드가 저농도일 때부터 작용하는 Ⅱ형과 아세트알데히드가 고농도로 되어야 작용을 하는 Ⅰ형이 있다. 동양인은 타인종과 비교하여 Ⅱ형 아세트알데히드효소가 결핍되어 있거나, 부족하므로 아세트알데히드의 분해가 느리다. 따라서, 분해되지 않고 체내에 축적된 아세트알데히드에 의해 각종 숙취 현상을 더 많이 느끼게 되는 경우가 많다.There are two types of acetaldehyde dehydrogenase, type II, which works from a low concentration of acetaldehyde, and type I, which works only when acetaldehyde has a high concentration. Asians are deficient in acetaldehyde because they lack or lack type II acetaldehyde enzymes compared to other species. Therefore, various hangover phenomena are often felt by acetaldehyde accumulated in the body without being decomposed.
알코올성 간질환에는 간 세포내 중성지방(Triglyceride)의 축적에 의한 지방간(fatty liver), 알코올에 의한 염증성 손상을 일으키는 알코올성 간염(hepatitis), 이러한 간의 만성염증으로 간조직이 섬유화 조직으로 변형되는 간경변증(liver cirrhosis) 등이 있다.Alcoholic liver disease includes fatty liver caused by accumulation of triglyceride in the liver cells, alcoholic hepatitis causing inflammatory damage caused by alcohol, and liver cirrhosis in which liver tissue is transformed into fibrotic tissue due to chronic inflammation of the liver ( liver cirrhosis).
따라서, 현재까지 과도한 음주에 따른 숙취를 해소하기 위한 제품에 대한 연구가 다양하게 진행되어 왔으며, 그 결과 다양한 건강보조식품이 개발되고 있다.Accordingly, various researches have been conducted on products to eliminate hangovers due to excessive drinking, and as a result, various health supplements have been developed.
현재까지 한국 식품의약품안전처가 "간 건강에 도움"으로 효능을 개별 인정한 원료에는 밀크씨슬 추출물, 브로콜리스프라우트 분말, 표고버섯 균사체, 표고버섯 균사체 추출물, 복분자 추출 분말 등이 있고, "알코올성 손상으로부터 간 보호에 도움"으로 효능을 개별 인정한 원료에는 헛개나무과병 추출물, 유산균 발효 다시마 추출물 등이 있다. So far, the Korea Food and Drug Administration has recognized individual efficacy as "help for liver health", including milk thistle extract, broccolisprout powder, shiitake mushroom mycelium, shiitake mushroom mycelium extract, and bokbunja extract powder. Some of the ingredients that have been individually recognized for their efficacy as a "protection of the liver" include filariasis extract and lactic acid bacteria fermented kelp extract.
최근 10년간 상기 예시의 원료를 사용한 각종 제제 형태의 식품들이 개발되었는데 그 중 대다수는 드링크제에 국한되어 있다. 또한, 이러한 제품들은 간 기능 개선 및 숙취해소 효과를 과학적으로 입증하는데 있어 일부의 생리적 개선 효과만 있거나 임상적으로 효과가 미미한 것으로 판단되고 있다.In the past 10 years, various types of food products have been developed using the above-described raw materials, many of which are limited to drinks. In addition, these products are considered to have only some physiological improvement effects or clinically insignificant effects in scientifically proving the effect of improving liver function and relieving hangover.
이에 따라, 음주로 인한 숙취증상을 해소하고 알코올성 손상으로부터 간 보호에 도움이 되는 기능성이 더욱 향상된 식품 조성물의 개발에 대한 필요성이 높아지고 있다.Accordingly, there is an increasing need for the development of a food composition with improved functionality that resolves hangover symptoms caused by drinking alcohol and helps protect the liver from alcoholic damage.
본 발명은 상기와 같은 종래 기술의 문제점을 해결하기 위하여 안출된 것으로서, 본 발명에서 해결하고자 하는 과제는 헛개나무 열매 추출 농축액을 기반으로 하여 각종 생약 및 식물성 생리활성 물질을 함유하는 숙취해소용 조성물을 제공하고자 하는 것이다.The present invention was devised to solve the problems of the prior art as described above, and the problem to be solved in the present invention is a composition for releasing hangovers containing various herbal and vegetable bioactive substances based on the extract of hawthorn fruit extract. Is to provide.
상기와 같은 과제를 해결하기 위하여, 본 발명은 헛개나무 열매 추출 농축액 100중량부에 대하여, 갈근 농축액 1-2중량부, 대추 농축액 18-19중량부, 아스파라긴 36-38중량부, 액상과당 370-375중량부, 타우린 0.3-0.4중량부, 구연산 18-19중량부, 구연산나트륨 11-12중량부, 비타민 B1 7-8중량부, 니코틴산아미드 11-12중량부, 카라멜색소 0.7-0.8중량부, 안식향산나트륨 2-3중량부, 허브향 18-19중량부 및 정제수 3,100-3,200중량부를 포함하는 숙취해소용 조성물을 제공한다.In order to solve the problems as described above, the present invention, with respect to 100 parts by weight of the extract of hawthorn fruit extract, 1-2 parts by weight of the root extract, 18-19 parts by weight of the jujube concentrate, 36-38 parts by weight of asparagine, 370-fructose liquid 375 parts by weight, taurine 0.3-0.4 parts by weight, citric acid 18-19 parts by weight, sodium citrate 11-12 parts by weight, vitamin B1 7-8 parts by weight, nicotinic acid amide 11-12 parts by weight, caramel color 0.7-0.8 parts by weight, Provided is a composition for relieving hangover, including 2-3 parts by weight of sodium benzoate, 18-19 parts by weight of herbal fragrance and 3,100-3,200 parts by weight of purified water.
본 발명의 상기 숙취해소용 조성물에는 헛개나무 열매 추출 농축액 100중량부에 대하여, 미선나무 추출 농축액 2-3중량부를 더 포함하는 것이 바람직하다.It is preferable that the composition for relieving hangover of the present invention further includes 2-3 parts by weight of the extract of stalk extract, based on 100 parts by weight of the concentrated extract of hawthorn fruit.
본 발명의 상기 숙취해소용 조성물에는 헛개나무 열매 추출 농축액 100중량부에 대하여, 화분 추출 농축액 1-2중량부를 더 포함하는 것이 바람직하다.It is preferable that the composition for relieving hangover of the present invention further includes 1-2 parts by weight of the pollen extract concentrate with respect to 100 parts by weight of the extract of pear fruit extract.
본 발명의 상기 숙취해소 조성물에는 헛개나무 열매 추출 농축액 100중량부에 대하여, 갯방풍 추출 농축액 2-3중량부를 더 포함하는 것이 바람직하다.The hangover-removing composition of the present invention, it is preferable to further contain 2-3 parts by weight of baekbang wind extract concentrate with respect to 100 parts by weight of the extract of hawthorn fruit extract.
본 발명의 숙취해소용 조성물은 숙취해소에 효과가 좋은 헛개나무 열매의 추출 농축액을 기반으로 각종 생약 및 식물성 생리활성 성분을 함유하고 있어, 숙취해소에 탁월한 효과가 있고, 액상, 환 등으로 조제하여 간편하게 복용할 수 있으므로 건강 기능 식품 산업상 매우 유용한 발명이다.The composition for relieving a hangover of the present invention contains various herbal and vegetable bioactive ingredients based on the extract concentrate of the hawthorn fruit which is effective in relieving a hangover, and has an excellent effect on relieving a hangover, and is prepared by liquid, pills, etc. Since it can be easily taken, it is a very useful invention in the health food industry.
도 1은 본 발명의 숙취해소 조성물로부터 제조된 액상형 음료 제품을 나타낸 사진이다.1 is a photograph showing a liquid beverage product prepared from the hangover relief composition of the present invention.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 발명자는 기존에 다양하게 시판되는 숙취해소용 음료가 숙취해소에 그리 효과가 우수하지 못한 점을 발견하고, 보다 효능이 우수한 숙취해소용 조성물을 개발하기 위한 연구를 거듭한 결과, 아래와 같은 성분 및 함량을 가진 조성물이 탁월한 숙취해소 효능이 있음을 확인하고 본 발명을 완성하였다.The inventors of the present invention have found that various commercially available beverages for hangover remediation are not very effective in relieving hangover, and as a result of conducting research to develop more effective hangover relieving compositions, as follows: It was confirmed that the composition with ingredients and contents had excellent hangover-relieving efficacy and completed the present invention.
본 발명은 헛개나무 열매 추출 농축액 100중량부에 대하여, 갈근 농축액 1-2중량부, 대추 농축액 18-19중량부, 아스파라긴 36-38중량부, 액상과당 370-375중량부, 타우린 0.3-0.4중량부, 구연산 18-19중량부, 구연산나트륨 11-12중량부, 비타민 B1 7-8중량부, 니코틴산아미드 11-12중량부, 카라멜색소 0.7-0.8중량부, 안식향산나트륨 2-3중량부, 허브향 18-19중량부 및 정제수 3,100-3,200중량부를 포함하는 숙취해소용 조성물을 제공한다.The present invention, with respect to 100 parts by weight of the extract of hawthorn fruit extract, 1-2 parts by weight of root extract, 18-19 parts by weight of jujube concentrate, 36-38 parts by weight of asparagine, 370-375 parts by weight of fructose, 0.3-0.4 parts by weight of taurine Parts, 18-19 parts by weight of citric acid, 11-12 parts by weight of sodium citrate, 7-8 parts by weight of vitamin B1, 11-12 parts by weight of nicotinamide, 0.7-0.8 parts by weight of caramel color, 2-3 parts by weight of sodium benzoate, herbs Provided is a hangover-relieving composition comprising 18-19 parts by weight of fragrance and 3,100-3,200 parts by weight of purified water.
본 발명의 상기 숙취해소용 조성물에는 상기 언급된 각 성분 이외에 헛개나무 열매 추출 농축액 100중량부에 대하여, 미선나무 추출 농축액 2-3중량부를 더 포함하는 것이 바람직하다.It is preferable that the composition for relieving hangover of the present invention further includes 2-3 parts by weight of the extract of the stalk of the pear tree, with respect to 100 parts by weight of the extract of pear tree fruit extract in addition to each of the components mentioned above.
또한, 본 발명의 상기 숙취해소용 조성물에는 상기 언급된 각 성분 이외에 헛개나무 열매 추출 농축액 100중량부에 대하여, 화분 추출 농축액 1-2중량부를 더 포함하는 것이 바람직하다.In addition, the composition for releasing the hangover of the present invention preferably further contains 1-2 parts by weight of the pollen extract concentrate with respect to 100 parts by weight of the extract of oleander fruit extract in addition to each of the above-mentioned components.
또한, 본 발명의 상기 숙취해소 조성물에는 상기 언급된 각 성분 이외에 헛개나무 열매 추출 농축액 100중량부에 대하여, 갯방풍 추출 농축액 2-3중량부를 더 포함하는 것이 바람직하다.In addition, it is preferable that the hangover relief composition of the present invention further contains 2-3 parts by weight of the Gaetbangpung extract concentrate, based on 100 parts by weight of the extract of oleander extract in addition to each of the above-mentioned components.
상기 "추출"이라는 용어는 각 식물체로부터 열수 또는 에탄올 등의 용매로 유용 성분을 회수하는 방법을 의미한다. 바람직한 구체예로서, 본 발명의 추출은 각 식물을 건조 및 세절한 후 열수에 침지시켜 1~3시간 동안 2~3회 반복 추출하여 수득될 수 있다. The term "extraction" means a method for recovering useful components from each plant with hot water or a solvent such as ethanol. As a preferred embodiment, the extraction of the present invention can be obtained by repeatedly extracting 2-3 times for 1 to 3 hours by immersing each plant in dry water and immersing it in hot water.
상기 "농축"이라는 용어는 식물체로부터 추출물을 조제한 후, 이로부터 수분을 제거하여 유용 성분의 농도를 증가시키는 방법을 의미하며, 바람직한 구체예로서, 추출물을 농축기에 투입하여 진액 형태의 농축액을 회수하여 사용한다.The term "concentration" refers to a method of preparing an extract from a plant and removing moisture therefrom to increase the concentration of useful components. In a preferred embodiment, the extract is put into a concentrator to recover the concentrate in the form of a essence. use.
본 발명의 숙취해소용 조성물은 액상 또는 환으로 조제하여 사용될 수 있다. 액상의 경우, 상기 언급된 각 성분을 혼합 및 가열하여 용기에 담아 살균 후 제품화시키며, 환의 경우, 제조된 액상 타입의 조성물에 공지의 환약 제조 방법에 따라 환으로 제조하여 제품화시킬 수 있다.The composition for relieving hangover of the present invention may be used in a liquid form or as a ring. In the case of a liquid, each component mentioned above is mixed and heated to be put into a container and sterilized to produce a product, and in the case of a ring, it can be manufactured into a ring according to a known method for manufacturing pills in a prepared liquid type composition.
이하에서는, 구체적인 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 하기 실시예는 본 발명의 바람직한 일 구체예를 기재한 것이며, 하기 실시예에 기재된 사항에 의하여 본 발명의 권리범위가 한정되어 해석되는 것은 아니다.Hereinafter, the present invention will be described in more detail through specific examples. The following examples describe one preferred embodiment of the present invention, and the scope of the present invention is not limited by the matters described in the following examples.
<실시예><Example>
실시예 1Example 1
헛개나무 열매 추출 농축액 2.7중량%, 갈근 농축액 0.05중량%, 대추 농축액 0.50중량%, 아스파라긴 1.00중량%, 액상과당 10.00중량%, 타우린 0.01중량%, 구연산 0.50중량%, 구연산나트륨 0.30중량%, 비타민 B1 0.20중량%, 니코틴산아미드 0.30중량%, 카라멜색소 0.02중량%, 안식향산나트륨 0.055중량%, 허브향 0.50중량% 및 잔여의 정제수를 첨가하여 액상의 조성물을 조제하였다.Raspberry Fruit Extract Concentrate 2.7 wt%, Brown Root Concentrate 0.05 wt%, Jujube Concentrate 0.50 wt%, Asparagine 1.00 wt%, Liquid Fructose 10.00 wt%, Taurine 0.01 wt%, Citric Acid 0.50 wt%, Sodium Citrate 0.30 wt%, Vitamin B1 A liquid composition was prepared by adding 0.20% by weight, 0.30% by weight of nicotinic acid amide, 0.02% by weight of caramel color, 0.055% by weight of sodium benzoate, 0.50% by weight of herbal flavor and residual purified water.
실시예 2Example 2
미선나무 열수 추출 농축액 0.06중량%를 더 첨가한 것을 제외하고는 실시예 1과 동일한 방법으로 액상의 조성물을 제조하였다.A liquid composition was prepared in the same manner as in Example 1, except that 0.06% by weight of the stalk tree hot water extract concentrate was further added.
실시예 3Example 3
화분 열수 추출 농축액 0.06중량%를 더 첨가한 것을 제외하고는 실시예 2와 동일한 방법으로 액상의 조성물을 제조하였다.A liquid composition was prepared in the same manner as in Example 2, except that 0.06% by weight of pollen hot water extract concentrate was further added.
실시예 4Example 4
갯방풍 열수 추출 농축액 0.06중량%를 더 첨가한 것을 제외하고는 실시예 3과 동일한 방법으로 액상의 조성물을 제조하였다.A liquid composition was prepared in the same manner as in Example 3, except that 0.06% by weight of Gaetbangpung hot water extract concentrate was further added.
비교예 Comparative example
시판 중인 C사 숙취해소용 음료를 사용하였다.A commercially available beverage from C company hangover was used.
실험예Experimental Example
실시예 1 내지 실시예 3 및 비교예의 숙취해소 음료를 성인 남녀 40인을 대상으로 효능을 평가하였다. 대상은 각 그룹별로 남녀 각 5인 총 10인으로 하여 4그룹으로 나누었고, 각 평가자에게 맥주 500ml 및 소주 3잔을 음주하게 한 후, 제1그룹에는 실시예 1의 숙취해소 음료를 제공하고, 제2그룹에는 실시예 2의 숙취해소 음료를 제공하고, 제3그룹에는 실시예 3의 숙취해소 음료를 제공하고, 제4그룹에는 비교예의 숙취해소 음료를 제공하였다. 숙취해소 음료를 음주 전후에 복용한 후, 취침하고, 8시간 후 기상하여 아래 각 항목별로 5점 척도법에 따라 평가하여 그 결과를 나타내었다(1점: 매우 나쁨, 2점: 나쁨, 3점: 보통, 4점: 좋음, 5점: 아주 좋음).The efficacy of the hangover-relieving beverages of Examples 1 to 3 and Comparative Examples was evaluated for 40 adults. The subjects were divided into 4 groups of 5 men and 5 women in each group, and after each evaluator drunk 500 ml of beer and 3 glasses of soju, the first group was provided with a hangover relieving beverage of Example 1, and The second group provided the hangover-releasing beverage of Example 2, the third group provided the hangover-releasing beverage of Example 3, and the fourth group provided the hangover-releasing beverage of the comparative example. After taking a drink before and after drinking, sleeping, and waking up after 8 hours, each item was evaluated according to the 5-point scale method (1 point: very bad, 2 points: bad, 3 points: Normal, 4 points: Good, 5 points: Very good).
상기 표 1에 나타난 바와 같이, 본 발명의 실시예 1 내지 실시예 3의 숙취해소음료는 시판되는 비교예의 숙취해소음료와 비교하여 음주 후 두통 및 매스꺼움 등이 현저히 감소함을 알 수 있었고, 전체적인 숙취해소의 정도도 양호한 것으로 나타났다. 특히, 실시예 1 내지 실시예 3의 경우에, 실시예 1보다는 실시예 2가, 실시예 2보다는 실시예 3에서 숙취해소 효과가 보다 우수함을 확인할 수 있었다.As shown in Table 1, the hangover cancellation beverages of Examples 1 to 3 of the present invention were found to have significantly reduced headache and nausea after drinking compared to the hangover cancellation beverages of commercially available comparative examples, and overall hangover The degree of resolution was also found to be good. Particularly, in the case of Examples 1 to 3, it was confirmed that Example 2 was more effective in Example 3 than Example 2, and Example 3 was better in Example 3 than Example 2.
Claims (4)
With respect to 100 parts by weight of the extract of hawthorn fruit extract, 1-2 parts by weight of root extract, 18-19 parts by weight of jujube concentrate, 36-38 parts by weight of asparagine, 370-375 parts by weight of liquid fructose, 0.3-0.4 parts by weight of taurine, citric acid 18-19 parts by weight, sodium citrate 11-12 parts by weight, vitamin B1 7-8 parts by weight, nicotinic acid amide 11-12 parts by weight, caramel color 0.7-0.8 parts by weight, sodium benzoate 2-3 parts by weight, herbal fragrance 18- A composition for relieving hangover, including 19 parts by weight and 3,100-3,200 parts by weight of purified water.
The composition for relieving a hangover according to claim 1, further comprising 2-3 parts by weight of the extract of the stalk of the pear tree, based on 100 parts by weight of the extract of the pear tree fruit extract.
The composition for releasing hangovers according to claim 2, further comprising 1-2 parts by weight of the pollen extract concentrate with respect to 100 parts by weight of the extract of pear tree fruit extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190009909A KR20200092692A (en) | 2019-01-25 | 2019-01-25 | Composition for hangover cures |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190009909A KR20200092692A (en) | 2019-01-25 | 2019-01-25 | Composition for hangover cures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20200092692A true KR20200092692A (en) | 2020-08-04 |
Family
ID=72049006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020190009909A Ceased KR20200092692A (en) | 2019-01-25 | 2019-01-25 | Composition for hangover cures |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20200092692A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102669184B1 (en) * | 2023-08-31 | 2024-05-29 | 하상욱 | Composition for relieving hangovers and improving liver comprising herbal medicine and powder material and method for preparing thereof |
| CN118266586A (en) * | 2024-05-11 | 2024-07-02 | 中粮营养健康研究院有限公司 | Composite plant product and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100442771B1 (en) | 2000-11-17 | 2004-08-04 | 주식회사 바이오썸 | Drink for mitigating hangover and the manufacturing method thereof |
| KR20120123860A (en) | 2011-05-02 | 2012-11-12 | 보해양조주식회사 | Composition for relieving hangover or improving liver function |
| KR20140070470A (en) | 2012-11-30 | 2014-06-10 | 주식회사유한양행 | Composition for relieving and preventing hangover comprising Dendropanax morbifera extract |
| KR101935861B1 (en) | 2017-11-16 | 2019-01-07 | 인산죽염 주식회사 | Functional food composition for removing hangover and improving liver function and manufacturing method for thereof |
-
2019
- 2019-01-25 KR KR1020190009909A patent/KR20200092692A/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100442771B1 (en) | 2000-11-17 | 2004-08-04 | 주식회사 바이오썸 | Drink for mitigating hangover and the manufacturing method thereof |
| KR20120123860A (en) | 2011-05-02 | 2012-11-12 | 보해양조주식회사 | Composition for relieving hangover or improving liver function |
| KR20140070470A (en) | 2012-11-30 | 2014-06-10 | 주식회사유한양행 | Composition for relieving and preventing hangover comprising Dendropanax morbifera extract |
| KR101935861B1 (en) | 2017-11-16 | 2019-01-07 | 인산죽염 주식회사 | Functional food composition for removing hangover and improving liver function and manufacturing method for thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102669184B1 (en) * | 2023-08-31 | 2024-05-29 | 하상욱 | Composition for relieving hangovers and improving liver comprising herbal medicine and powder material and method for preparing thereof |
| CN118266586A (en) * | 2024-05-11 | 2024-07-02 | 中粮营养健康研究院有限公司 | Composite plant product and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
| US8637098B2 (en) | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | |
| KR102001740B1 (en) | Liquid composition for preventing and relieving hangover with high content of ginsenoside F2, R3 and compound K comprising and preparation method thereof | |
| KR101601947B1 (en) | Beverage composition for relieving hangover comprising peanut sprouts and manufacturing method thereof | |
| CN114631632B (en) | Rosa roxburghii composition for protecting liver and dispelling effects of alcohol, and preparation and application thereof | |
| CN102994305A (en) | Method for preparing health-care food (therapy) product (nutrient juice wine) by use of extracts from cordyceps militaris and cocoon | |
| KR101525478B1 (en) | Food composition for relieving hangover | |
| CN101953467B (en) | Composition containing natto freeze-dried powder and application thereof | |
| KR101665584B1 (en) | Composition for eliminating hangover | |
| KR101729003B1 (en) | Composition For Preventing or Treating Gout Containing Extracts or Fermentation Metabolites of Dendropanax morbiferus | |
| KR101093998B1 (en) | Functional composition for relieving hangovers and improving liver function | |
| KR20200092692A (en) | Composition for hangover cures | |
| KR101461165B1 (en) | Hangover curing agent | |
| KR102634131B1 (en) | Composition for Liver Function Improvement Comprising Natural Extracts | |
| KR101394358B1 (en) | Health composition relieving alcohol hangover | |
| CN111297963B (en) | Extract and composition for dispelling effects of alcohol and protecting liver as well as preparation method and application of extract and composition | |
| KR20060117550A (en) | Hangover composition and its manufacturing method | |
| KR102238009B1 (en) | Red ginseng products containing noni and the process for the preparation thereof | |
| CN102987501B (en) | Method for preparing nutrient (liquid) beverages and granules of healthcare food (therapy) products by using extractives of cordyceps militaris and cocoons | |
| KR101897005B1 (en) | Composition for Relieving Hangover Using Ginsenoside Compound K | |
| KR20200142768A (en) | Composition for hangover cure conprising oriental herbal extract | |
| CN111686236B (en) | Capsule for dispelling effects of alcohol, protecting liver and protecting brain | |
| KR101795261B1 (en) | Medicinal-Herb Composition Comprising Chinese matrimony vine for Treatmenting and Protecting the Insomniac and the Method of Making the Same | |
| KR101930026B1 (en) | manufacturing method of black garlic beverage having effect to improve liver function | |
| KR101725261B1 (en) | Composition for the dissolving of the alcohol consistencies in blood and the neutralizing poisons of the hangover |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190125 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200625 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20201015 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20210422 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20201015 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20200625 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |